−1.0 TWD
−92.04 M TWD
18.91 M TWD
64.07 M
About GONGWIN BIOPHARM HOLDINGS CO LTD
Sector
Industry
CEO
Mao Yuan Lin
Website
Headquarters
Taipei
Founded
2014
FIGI
BBG00FVJJ526
Gongwin Biopharm Holdings Co., Ltd. engages in the operation of Minimally Invasive Targeted Tumor Ablation business. It is a technology of minimally invasive treatment and can be directly applied to the treatment of various solid malignant tumors. Its products include PTS Minimally-Invasive Targeted Ablation and anti-tumor for canine used such as superficial malignant tumor in canine, malignant melanoma of the canine, lipoma of the canine and feline, and malignant bladder tumor of the canine and feline. The company was founded by John Wu and Rocky Shih on March 27, 2014 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6617 is 110.5 TWD — it has decreased by −1.33% in the past 24 hours. Watch GONGWIN BIOPHARM HOLDINGS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GONGWIN BIOPHARM HOLDINGS CO LTD stocks are traded under the ticker 6617.
6617 stock has risen by 2.29% compared to the previous week, the month change is a 0.90% rise, over the last year GONGWIN BIOPHARM HOLDINGS CO LTD has showed a −39.45% decrease.
6617 reached its all-time high on Aug 17, 2022 with the price of 457.0 TWD, and its all-time low was 45.5 TWD and was reached on Jul 19, 2017. View more price dynamics on 6617 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6617 stock is 3.21% volatile and has beta coefficient of −0.13. Track GONGWIN BIOPHARM HOLDINGS CO LTD stock price on the chart and check out the list of the most volatile stocks — is GONGWIN BIOPHARM HOLDINGS CO LTD there?
Today GONGWIN BIOPHARM HOLDINGS CO LTD has the market capitalization of 14.37 B, it has increased by 1.35% over the last week.
Yes, you can track GONGWIN BIOPHARM HOLDINGS CO LTD financials in yearly and quarterly reports right on TradingView.
6617 net income for the last quarter is −9.79 M TWD, while the quarter before that showed −25.55 M TWD of net income which accounts for 61.69% change. Track more GONGWIN BIOPHARM HOLDINGS CO LTD financial stats to get the full picture.
No, 6617 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GONGWIN BIOPHARM HOLDINGS CO LTD EBITDA is −140.85 M TWD, and current EBITDA margin is −636.46%. See more stats in GONGWIN BIOPHARM HOLDINGS CO LTD financial statements.
Like other stocks, 6617 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GONGWIN BIOPHARM HOLDINGS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GONGWIN BIOPHARM HOLDINGS CO LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GONGWIN BIOPHARM HOLDINGS CO LTD stock shows the sell signal. See more of GONGWIN BIOPHARM HOLDINGS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.